Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Takahiro Yanase

Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients With Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy

Asian Pacific Journal of Cancer Prevention

2019

English

Examination of Diagnostic Accuracy of UroVysion Fluorescence in Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients

Asian Pacific Journal of Cancer Prevention

2019

English

A Case of Laparoscopic Fenestration Surgery for Pelvic Lymphocele Occurring After Laparoscopic Radical Prostatectomy

Journal of Rural Medicine

2019

English

Related publications

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy

2013

English

No Evidence for Changes in Skeletal Muscle Mass or Weight During First-Line Chemotherapy for Metastatic Colorectal Cancer

English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer

Cancer Research

Oncology

2018

English

Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

Erciyes Medical Journal

Medicine

2019

English

Could Salvage Surgery After Chemotherapy Have Clinical Impact on Cancer Survival of Patients With Metastatic Urothelial Carcinoma?

International Journal of Clinical Oncology

English

Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Takahiro Yanase

Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients With Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy

Examination of Diagnostic Accuracy of UroVysion Fluorescence in Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients

A Case of Laparoscopic Fenestration Surgery for Pelvic Lymphocele Occurring After Laparoscopic Radical Prostatectomy

Related publications

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

No Evidence for Changes in Skeletal Muscle Mass or Weight During First-Line Chemotherapy for Metastatic Colorectal Cancer

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

Could Salvage Surgery After Chemotherapy Have Clinical Impact on Cancer Survival of Patients With Metastatic Urothelial Carcinoma?

Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France